Hua Medicine (02552) reported that its total authorized share capital remained at USD 2,000,000, with no changes during the month of October 2025. The company’s total issued shares also stayed unchanged at 1,056,605,016.
According to the Post-IPO Share Option Scheme, the number of outstanding share options decreased slightly, from 59,569,669 to 59,289,669, reflecting 280,000 lapsed options. No other share warrant, convertible, or agreement-related movements were disclosed for October 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.